LCN2 and psoriasis: Our meta-analysis indicated that serum lipocalin-2 levels were significantly higher in psoriasis/PsA patients than in controls (SMD: 0.757, 95%CI = 0.588‐0.926, and PH = 0.114; PH is the P value for the heterogeneity test).